The Malaria Heart Disease Study

NCT04445103 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 597

Last updated 2022-07-19

No results posted yet for this study

Summary

The Malaria Heart Disease Study is a prospective longitudinal cohort study of a random sample of approximately 1200 individuals from the state of Acre in Brazil. The overall hypothesis is that patients who have (i) previously suffered from a malaria infection or (ii) patients with ongoing symptomatic malaria will benefit from having an echocardiogram and blood tests performed as a screening tool to diagnose early cardiac impairment and prevent future cardiovascular disease.

Conditions

Interventions

DIAGNOSTIC_TEST

Assessment of cardiac function

Echocardiographic examination and assessment of cardiac biomakers

Sponsors & Collaborators

  • Federal University of Acre

    collaborator UNKNOWN
  • University of Sao Paulo

    collaborator OTHER
  • Independent Research Fund Denmark

    collaborator INDUSTRY
  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Philip Brainin, MD, PhD · Federal University of Acre

  • Odilson Silvestre, MD, PhD, MPH · Federal University of Acre

  • Tor Biering-Sørensen, MD, PhD, MPH · Gentofte University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-21
Primary Completion
2021-01-25
Completion
2021-01-25

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445103 on ClinicalTrials.gov